NeoGenomics Faces Revenue Shortfall Despite Strong Growth

United States, Wednesday, 30 April 2025.
NeoGenomics reported a 7.5% year-on-year revenue growth to $168 million for Q1 2025, failing to meet analysts’ expectations of $170.9 million, yet raised its full-year revenue guidance.